🇮🇱 Hu1124 in Israel

Hu1124 (EFALIZUMAB) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Hu1124 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Israel

Frequently asked questions

Is Hu1124 approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Hu1124 in Israel?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.